Clinical Trials Browser

Has results × Thyroid Neoplasms × Everolimus × Clear all

NCT00936858 2021-10-22

RAD001 for Patients With Radioiodine Refractory Thyroid Cancer

Phase 2 Completed

50 enrolled 14 charts

Thyroid Neoplasms

NCT01270321 2021-02-17

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

Phase 2 Completed

42 enrolled 11 charts

Thyroid Neoplasms